Starling Oncology Warrant
STLNW
STLNW was delisted on the 13th of November, 2026.
12 hedge funds and large institutions have $200K invested in Starling Oncology Warrant in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
99% less capital inflows, than outflows
Capital inflows: $3.17K | Capital outflows: $543K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wolverine Asset Management
Chicago,
Illinois
|
+$2.4K |
| 2 |
HRT Financial
New York
|
+$763 |
| 3 |
Clear Street
New York
|
+$5 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$543K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$49 |
STLNW Hedge Fund Activity: Q3 2026 in Review
12 of the 8,114 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Warrant (STLNW) for Q3 2026, worth a combined $200K — down 72% from $707K a quarter earlier.
Fund positioning in STLNW was balanced in Q3 2026: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $2.4K. The largest seller was Oasis Management Company, exiting entirely with an estimated $543K sold.
- 12 institutional investors held Starling Oncology Warrant (STLNW) as of Q3 2026, unchanged from Q2 2026.
- Funds reported $200K of Starling Oncology Warrant stock for Q3 2026, down 72% quarter-over-quarter.
- 1 fund opened new Starling Oncology Warrant positions in Q3 2026 and 1 closed out, a net change of 0 holders.
- The largest Starling Oncology Warrant buyer in Q3 2026 was Wolverine Asset Management, an estimated $2.4K added.
- The largest Starling Oncology Warrant seller in Q3 2026 was Oasis Management Company, an estimated $543K sold.
Based on aggregated 13F filings for Q3 2026.